Dallas, TX -- (SBWIRE) -- 09/05/2014 -- The global flow cytometry market is expected to reach $3.7 billion by 2018, at a CAGR of 10% from 2013 to 2018. Increasing applications of technological advancements in flow cytometry instruments, fostering research activities in the field of life sciences, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery and development of user friendly and intuitive software’s are driving the growth of the flowcytometry market

Additionally, emerging markets such as China and India, development of high throughput flow cytometry, and fostering stem cells research unfolds new opportunities for the market players.

Browse 103 market data tables and 16 figures spread through 270 slides and in-depth TOC on “Flow Cytometry Market”
http://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html

On the basis of the type of applications, the global market is classified into three categories, namely, research fields, clinical applications, and industrial applications. Research fields commands the major chunk of the global market in 2013; while, the clinical application is the fastest growing segment in this market. On the basis of the end users, the global flow cytometry market has been segmented into commercial organizations, hospitals, academic institutes, medical schools, and clinical testing labs. Commercial organization commanded the major chunk of the global market in 2013 and is the fastest growing segment along with clinical testing labs in this market.

In the report, the global market is further segmented on the basis of type of end users, which includes commercial organizations, hospitals, academic institutions, medical schools, and clinical testing labs. In 2013, the commercial organization segment accounted for the largest share of 35% in the market. Likewise, based on the type of applications, the global market is classified into three categories, namely, research, clinical, and industrial applications. Application of flow cytometry in the research fields commands the major chunk of the market in 2013.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=65374584

On the basis of products, the global flow cytometry market has been segmented into instruments, reagents and consumables, software, services, and accessories. In 2013, the reagents and consumables segment accounted for the largest share of 45%in the global market, and is also expected to grow at the highest CAGR of 11.2% from 2013 to 2018. In addition, the global market is classified into three segments based on the type of technology, namely, cell-based, bead-based, and others. The cell-based segment accounted for the largest share of 80% in the global market

Geographically, the global flow cytometry market is divided into four regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America and a major part of the European region are saturated markets for this product. North America accounted for the largest share of the global market in 2013. This growth is attributed to a number of factors such as presence of flow cytometry associations in this region, increasing use of flow cytometry techniques in cancer research, rise in investment initiatives by the government, and high quality infrastructure for clinical and laboratory research.

For Customization of Report: http://www.marketsandmarkets.com/requestCustomization.asp?id=65374584

The emerging markets including China and India are becoming attractive for the companies engaged in the development and marketing of the products. Various economic developments and growing prevalence of HIV/AIDS, growing number of research initiatives, increasing government support, and growing focus of both international and domestic players are the key factors propelling the demand for flow cytometry products in the Asia-Pacific region.

The flow cytometry market is a diversified and competitive market. The key players in this market are Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), eBioscience, Inc. (U.S.), EMD Millipore Corporation (U.S.), Life Technologies Corporation (U.S.), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), and Partec GmbH (Germany).

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:

Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog:
http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn:
http://www.linkedin.com/company/marketsandmarkets